Vivotecnia Research SL

Vivotecnia Research SL is an SME in Tres Cantos - Madrid, Spain that has taken part in 2 EU-funded projects since 2010, receiving €635k in EU funding.

EU funding received€635k
EU projects2
As coordinator0
Running now0
First EU project2010
Latest project2017
CountrySpain
EU registration (PIC)987063950
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Vivotecnia Research SL's own share of each project, not the project's full budget.

  • Horizon 2020€455k · 1 project
  • FP7 (2007 to 2013)€180k · 1 project

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • nTRACKPartner

    Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regeneration

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €455ktheir share
  • CARE-MIPartner

    CARDIO REPAIR EUROPEAN MULTIDISCIPLINARY INITIATIVE

    FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

    €180ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • autoimmune diseases
  • cardiology
  • mortality
  • nanomedicine
  • nuclear medicine
  • personalized medicine
  • pharmaceutical drugs
  • stem cells
  • transplantation

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime